Related Experiment Video
Updated: Aug 15, 2026

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation
Published on: June 27, 2017
TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines
Stephen P Fink1, Debra Mikkola, James K V Willson
1Howard Hughes Medical Institute, Cleveland, OH 44106, USA.
Abstract:
Smad4 is a tumor suppressor gene that is commonly lost or mutated in colorectal and pancreatic cancers. The activated transforming growth factor-beta (TGF-beta) receptor phosphorylates Smad2 and Smad3, which then complex with Smad4 and translocate to the nucleus. Smad4 mutations when detected as present in some human cancers have been considered sufficient to inactivate TGF-beta signaling. In this work, we describe a colon cancer cell line, VACO-9M, that is Smad4 null when analysed by multiple assays. To study the role of Smad4 in TGF-beta-induced translocation of the receptor-activated Smads to the nucleus, we analysed by immunofluorescence the cellular localization of endogenous Smad2 and Smad3 after TGF-beta treatment of VACO-9M, plus four additional Smad4 null cell lines of breast (MDA-MB-468), or pancreatic (BxPC3, Hs766T, CFPAC-1) origin. In each cell line, TGF-beta treatment resulted in both Smad2 and Smad3 moving to the nucleus in a Smad4-independent fashion. Nuclear translocation of Smad2 and Smad3 was, however, not sufficient to activate reporters for TGF-beta-induced transcriptional responses, which were however restored by transient transfection of wild-type Smad4. We conclude that Smad4 is not required for nuclear translocation of Smad2 and Smad3, but is needed for activation of at least certain transcriptional responses.
Insights
Smad4 is not required for Smad2 and Smad3 nuclear translocation in cancer cells. However, Smad4 is essential for activating transforming growth factor-beta (TGF-beta) signaling and transcriptional responses.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Smad4 is a critical tumor suppressor gene frequently altered in colorectal and pancreatic cancers.
- Transforming growth factor-beta (TGF-beta) signaling, mediated by Smad proteins, is crucial in cellular processes and often dysregulated in cancer.
- Smad4 loss or mutation has been historically considered sufficient to abolish TGF-beta signaling.
Purpose of the Study:
- To investigate the role of Smad4 in the nuclear translocation of Smad2 and Smad3 upon TGF-beta stimulation.
- To determine if Smad4 is necessary for TGF-beta-induced transcriptional responses in Smad4-null cancer cell lines.
Main Methods:
- Utilized immunofluorescence to track the cellular localization of endogenous Smad2 and Smad3 in multiple Smad4-null cancer cell lines (colon, breast, pancreatic) after TGF-beta treatment.
- Assessed TGF-beta-induced transcriptional responses using reporter assays.
- Restored TGF-beta signaling by transfecting wild-type Smad4 into Smad4-null cells.
Main Results:
- TGF-beta treatment induced nuclear translocation of both Smad2 and Smad3 in all tested Smad4-null cell lines, demonstrating a Smad4-independent process.
- Nuclear localization of Smad2 and Smad3 alone was insufficient to activate TGF-beta-responsive reporter genes.
- Transient expression of wild-type Smad4 restored TGF-beta-induced transcriptional activity in these cells.
Conclusions:
- Smad4 is not essential for the nuclear import of Smad2 and Smad3 in response to TGF-beta.
- Smad4 plays a critical role in mediating TGF-beta-induced transcriptional activation, downstream of Smad2/Smad3 nuclear translocation.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
TGF - β Signaling Pathway

